-
Mashup Score: 0Landscape of neoadjuvant therapy in HER2-positive breast cancer: a systematic review and network meta-analysis - 2 year(s) ago
The recommended preoperative approach for HER2-positive breast cancer is unclear. We aimed to investigate the following: i) what is the optimal neoadjuvant regimen and ii) whether anthracyclines could be excluded.
Source: www.ejcancer.comCategories: Latest Headlines, Oncologists2Tweet
Neoadjuvant therapy for Her2+ breast cancer Network meta-analysis and systematic review supports dual antibody Drop the anthracycline and sub in Carbo (Free Full Text) https://t.co/sH0Odq270L https://t.co/CbsrEW5u86